Toshiba extends ultrasound reach in breast imaging
Toshiba America Medical Systems has positioned its MicroPure ultrasound technology as a way to better characterize microcalcifications. The new technology, showcased at RSNA 2008 on Toshiba’s Aplio XG ultrasound scanner, improves the detection of small calcifications that otherwise may evade detection with ultrasound.
Toshiba America Medical Systems has positioned its MicroPure ultrasound technology as a way to better characterize microcalcifications. The new technology, showcased at RSNA 2008 on Toshiba's Aplio XG ultrasound scanner, improves the detection of small calcifications that otherwise may evade detection with ultrasound.
The company also presented its work-in-progress ElastoQ, which displays differences in the relative elasticity of tumor and surrounding tissue by assigning colors to a tomographic image or, alternatively, as a graph. When using ElastoQ, tissue is examined while it is slightly compressed and then when it is decompressed. Cancerous tissue tends to have a significantly lower elasticity than healthy tissue. Like MicroPure, ElastoQ runs on the Toshiba Aplio XG.
Accompanying these advances is the company's new 18-MHz high-resolution Dynamic Micro Slice transducer for breast imaging.
The company is positioning its proprietary version of elastography as a possible future means to assess tumors, while framing MicroPure as a complementary way to detect small calcifications. Although ElastoQ is not yet cleared by the FDA, MicroPure has passed FDA review.
MicroPure has not yet been clinically validated, however, which is why the company is showing only early results from its clinical collaborators, leaving claims to a later date.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
